Brief: Spyre Therapeutics Inc - Expects $486.2 Million In Cash And Equivalents As Of Sept 30, 2025 - SEC Filing
14/10/2025 12:06
Oct 14 (Reuters) - Spyre Therapeutics Inc SYRE.O: SPYRE THERAPEUTICS INC - EXPECTS $486.2 MILLION IN CASH AND EQUIVALENTS AS OF SEPT 30, 2025 - SEC FILING Source text: [ID:n0001193125-25-237904] Further company coverage: SYRE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock